Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M79.7Revenue (TTM) $M3.5Net Margin (%)-787.3Altman Z-Score-22.3
Enterprise Value $M63.1EPS (TTM) $-0.4Operating Margin %-771.0Piotroski F-Score1
P/E(ttm)--Beneish M-Score-4.3Pre-tax Margin (%)-787.3Higher ROA y-yN
Price/Book7.910-y EBITDA Growth Rate %-17.5Quick Ratio4.3Cash flow > EarningsY
Price/Sales32.95-y EBITDA Growth Rate %11.2Current Ratio4.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-117.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M71.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARQL

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARQL is held by these investors:



ARQL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pucci PaoloCEO 2017-09-07Buy1,101$1.15-2.61view
Pucci PaoloCEO 2017-09-06Buy16,397$1.15-2.61view
Pucci PaoloCEO 2017-09-05Buy19,156$1.14-1.75view
Pucci PaoloCEO 2017-08-29Buy300$1.056.67view
Pucci PaoloCEO 2017-08-28Buy2,970$1.056.67view
Pucci PaoloChief Executive Officer 2017-08-25Buy9,492$1.056.67view
LOBERG MICHAEL DDirector 2015-12-17Buy3,719$2.16-48.15view
LOBERG MICHAEL DDirector 2015-12-16Buy1,231$2.14-47.66view
Pucci PaoloCEO 2015-12-15Buy1,283$2.16-48.15view
Pucci PaoloCEO 2015-12-11Buy1,108$2.1-46.67view

Quarterly/Annual Reports about ARQL:

News about ARQL:

Articles On GuruFocus.com
Jean-Marie Eveillard Increases Stakes in Cancer Therapeutics Company Arqule Inc May 05 2015 
Jean-Marie Eveillard Adds to Stake in Arqule Inc. May 03 2015 
ArQule Inc. Reports Operating Results (10-Q) Nov 09 2010 
ArQule Inc. Reports Operating Results (10-Q) Aug 04 2010 
ArQule Inc. Reports Operating Results (10-Q) May 06 2010 
ArQule Inc. (ARQL) CEO Paolo Pucci buys 5,000 Shares Nov 13 2009 
ArQule Inc. Reports Operating Results (10-Q) Aug 07 2009 
ArQule Inc. (ARQL) CEO Paolo Pucci buys 2,500 Shares May 15 2009 
ArQule Inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
ArQule to Present at the Cantor Fitzgerald Global Healthcare Conference on September 26, 2017 Sep 19 2017
Edited Transcript of ARQL earnings conference call or presentation 4-Aug-17 1:00pm GMT Aug 12 2017
ArQule reports 2Q loss Aug 04 2017
ArQule Reports Second Quarter 2017 Financial Results Aug 04 2017
Investor Network: ArQule, Inc. to Host Earnings Call Aug 04 2017
ArQule To Report Second Quarter 2017 Financial Results On August 4, 2017 Jul 21 2017
ArQule Announces First Patient Dosed in Phase 1 Trial of BTK Inhibitor, ARQ 531, for B-cell... Jul 11 2017
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating ArQule, Inc. for Potential... Jun 26 2017
ArQule Presents Preclinical Data for BTK Inhibitor, ARQ 531, at the 22nd Annual Congress of the... Jun 23 2017
ArQule Announces First Patient Dosed in Company Sponsored Phase 1/2 Trial of AKT Inhibitor, ARQ 092,... Jun 07 2017
ArQule Presents Phase 1/2 Clinical Data with ARQ 087 in Intrahepatic Cholangiocarcinoma at the 2017... Jun 03 2017
ArQule to Present Preclinical Data for BTK Inhibitor, ARQ 531, at the 22nd Annual Congress of the... May 18 2017
ArQule to Present Clinical Data at the 2017 American Society of Clinical Oncology (ASCO) Annual... May 17 2017
Edited Transcript of ARQL earnings conference call or presentation 3-May-17 1:00pm GMT May 03 2017
Arqule Reports First Quarter 2017 Financial Results May 03 2017
ArQule Announces Issuance of U.S. Patent Covering Composition of Matter of Proprietary Reversible... Apr 26 2017
ArQule To Report First Quarter 2017 Financial Results On May 3, 2017 Apr 19 2017
ArQule Receives Clearance of Investigational New Drug Application from the FDA for Proprietary... Apr 11 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}